Citigroup’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,157
| Closed | -$788K | – | 5841 |
|
|
2024
Q2 | $788K | Buy |
29,157
+22,624
| +346% | +$471K | ﹤0.01% | 3073 |
|
|
2024
Q1 | $120K | Sell |
6,533
-12,826
| -66% | -$204K | ﹤0.01% | 4224 |
|
|
2023
Q4 | $238K | Buy |
19,359
+18,563
| +2,332% | +$174K | ﹤0.01% | 3837 |
|
|
2023
Q3 | $11.9K | Sell |
796
-11,816
| -94% | -$246K | ﹤0.01% | 4505 |
|
|
2023
Q2 | $410K | Buy |
12,612
+11,654
| +1,216% | +$426K | ﹤0.01% | 3508 |
|
|
2023
Q1 | $37.5K | Sell |
958
-246
| -20% | -$12K | ﹤0.01% | 4338 |
|
|
2022
Q4 | $63.6K | Sell |
1,204
-317
| -21% | -$15.4K | ﹤0.01% | 4210 |
|
|
2022
Q3 | $68K | Sell |
1,521
-1,721
| -53% | -$74K | ﹤0.01% | 4262 |
|
|
2022
Q2 | $118K | Buy |
3,242
+758
| +31% | +$27.5K | ﹤0.01% | 4141 |
|
|
2022
Q1 | $103K | Sell |
2,484
-7,121
| -74% | -$251K | ﹤0.01% | 4397 |
|
|
2021
Q4 | $409K | Buy |
9,605
+4,929
| +105% | +$247K | ﹤0.01% | 3928 |
|
|
2021
Q3 | $257K | Buy |
4,676
+1,988
| +74% | +$104K | ﹤0.01% | 3994 |
|
|
2021
Q2 | $129K | Buy |
2,688
+74
| +3% | +$3.77K | ﹤0.01% | 4423 |
|
|
2021
Q1 | $132K | Sell |
2,614
-4,481
| -63% | -$249K | ﹤0.01% | 4234 |
|
|
2020
Q4 | $447K | Buy |
7,095
+4,825
| +213% | +$299K | ﹤0.01% | 4306 |
|
|
2020
Q3 | $153K | Sell |
2,270
-11,548
| -84% | -$630K | ﹤0.01% | 4810 |
|
|
2020
Q2 | $579K | Buy |
13,818
+9,185
| +198% | +$353K | ﹤0.01% | 4101 |
|
|
2020
Q1 | $146K | Sell |
4,633
-5,209
| -53% | -$209K | ﹤0.01% | 5012 |
|
|
2019
Q4 | $398K | Buy |
9,842
+6,999
| +246% | +$245K | ﹤0.01% | 4629 |
|
|
2019
Q3 | $93K | Sell |
2,843
-1,307
| -31% | -$52.1K | ﹤0.01% | 5732 |
|
|
2019
Q2 | $201K | Buy |
+4,150
| New | +$177K | ﹤0.01% | 5271 |
|
Other funds holding SILK
Citigroup's SILK Position: Q3 2024 in Review
Citigroup sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 29,157 shares — an estimated $788K sold.
Citigroup first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $788K in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Citigroup reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Citigroup sold 29,157 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $788K.
- Citigroup first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Citigroup's Silk Road Medical, Inc. Common Stock position peaked at $788K in Q2 2024.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.